Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 7.64%215.8M | 26.84%60.41M | -7.20%49.56M | 5.36%54.76M | 8.09%51.18M | -2.10%200.48M | -5.81%47.62M | -3.01%53.4M | 6.53%51.97M | -6.02%47.35M |
Net interest income | 6.34%166.25M | 6.83%42.85M | 6.16%41.85M | 7.81%41.35M | 4.57%40.2M | 4.53%156.33M | -1.21%40.11M | -1.18%39.43M | 6.35%38.35M | 16.48%38.44M |
-Net interest income | 11.31%266.78M | 2.47%66.98M | 9.45%68.33M | 14.48%66.34M | 20.75%65.13M | 41.81%239.68M | 28.21%65.36M | 38.97%62.43M | 51.05%57.95M | 55.25%53.94M |
-Interest income from loans and lease | 15.61%228.59M | 7.39%58.35M | 13.60%58.41M | 19.10%56.79M | 24.27%55.04M | 42.19%197.73M | 29.08%54.33M | 38.63%51.42M | 51.58%47.68M | 55.87%44.29M |
-Interest income from securities | -12.43%31.98M | -56.71%2.42M | -9.89%9.92M | -6.98%9.55M | 4.57%10.08M | 25.65%36.52M | -30.02%5.6M | 40.60%11.01M | 53.36%10.27M | 57.91%9.64M |
-Other interest income | 14.35%6.21M | ---- | ---- | ---- | ---- | 514.14%5.43M | ---- | ---- | ---- | ---- |
-Total interest expense | 20.61%100.53M | -4.45%24.13M | 15.11%26.48M | 27.52%24.99M | 60.88%24.93M | 328.59%83.35M | 143.35%25.25M | 357.54%23.01M | 750.98%19.6M | 790.52%15.5M |
-Interest expense for deposit | 23.47%92.69M | -2.44%22.55M | 17.93%24.46M | 31.01%22.88M | 65.77%22.81M | 430.53%75.08M | 170.53%23.11M | 472.22%20.74M | 1,335.94%17.46M | 1,694.00%13.76M |
-Interest expense for long term debt and capital securities | -5.31%7.83M | -26.09%1.58M | -10.79%2.02M | -0.98%2.12M | 22.13%2.12M | 56.21%8.27M | 16.69%2.14M | 61.23%2.26M | 96.60%2.14M | 78.31%1.74M |
Non interest income | 12.24%49.55M | 133.68%17.55M | -44.88%7.7M | -1.55%13.41M | 23.30%10.98M | -20.05%44.15M | -24.59%7.51M | -7.85%13.97M | 7.06%13.62M | -48.75%8.91M |
-Total premiums earned | 75.95%834K | 90.07%268K | 58.87%197K | 91.84%188K | 63.06%181K | 31.67%474K | --141K | --124K | -6.67%98K | -19.57%111K |
-Fees and commissions | 12.27%33.25M | 355.43%12.5M | -61.54%3.9M | -18.90%8.12M | 33.28%7.9M | -29.87%29.62M | -71.52%2.74M | 4.37%10.14M | -0.68%10.01M | -60.10%5.93M |
-Other non interest income | -5.84%6.47M | 9.05%2.93M | -1.74%1.58M | -33.36%971K | -3.24%1.73M | 9.63%6.87M | 254.84%2.69M | -37.88%1.61M | -10.72%1.46M | 20.44%1.79M |
-Gain loss on sale of assets | 25.17%9.01M | -4.17%1.86M | -3.57%2.02M | 100.97%4.13M | 8.43%1.17M | 12.95%7.2M | 14.24%1.94M | -26.53%2.1M | 126.54%2.06M | 19.34%1.08M |
Credit losses provision | 38.04%-4.12M | -1,123.29%-2.55M | 11.10%-1.6M | 103.48%119K | 94.40%-95K | -10.96%-6.65M | 118.18%249K | 48.94%-1.8M | -12.98%-3.42M | -187.91%-1.7M |
Non interest expense | 7.06%128.63M | 17.26%35.09M | 2.40%30.66M | 4.48%31.71M | 4.99%31.26M | -0.70%120.15M | -2.22%29.93M | -1.12%29.95M | 1.58%30.35M | -1.51%29.78M |
Occupancy and equipment | -0.82%11.57M | -0.89%2.88M | -2.52%2.83M | 2.16%2.83M | -1.85%3.03M | -9.68%11.66M | -7.95%2.91M | -4.95%2.9M | -11.06%2.77M | -14.02%3.09M |
Professional expense and contract services expense | 16.21%2.57M | 45.13%849K | 26.52%687K | 15.01%544K | -19.93%486K | 3.52%2.21M | -0.51%585K | -5.24%543K | -1.25%473K | 23.12%607K |
Selling and administrative expenses | 7.93%91.83M | 18.86%25.76M | 1.34%21.29M | 4.37%22.73M | 6.92%22.04M | -1.17%85.09M | -2.90%21.68M | -2.44%21.01M | 4.23%21.78M | -3.35%20.62M |
-General and administrative expense | 7.06%88.77M | 18.12%24.56M | 0.29%20.71M | 2.79%21.95M | 7.11%21.55M | -1.30%82.92M | -4.75%20.8M | -2.55%20.65M | 4.98%21.35M | -2.57%20.12M |
-Selling and marketing expense | 41.25%3.06M | 36.29%1.2M | 61.39%581K | 82.83%788K | -0.81%491K | 4.39%2.17M | 79.75%879K | 4.35%360K | -23.04%431K | -27.21%495K |
Depreciation amortization depletion | -5.67%516K | ---- | ---- | -5.84%129K | -5.84%129K | -30.32%547K | ---- | ---- | --137K | --137K |
-Depreciation and amortization | -5.67%516K | ---- | ---- | -5.84%129K | -5.84%129K | -30.32%547K | ---- | ---- | --137K | --137K |
Other non-interest expense | 7.29%22.15M | 20.66%5.08M | 6.66%5.86M | 5.52%5.47M | 4.59%5.58M | 8.22%20.65M | 12.29%4.21M | 7.16%5.49M | -3.66%5.18M | 10.58%5.33M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | 12.72%83.05M | 26.86%22.77M | -20.14%17.29M | 27.27%23.17M | 24.86%19.82M | -5.29%73.68M | -3.45%17.95M | 1.91%21.65M | 14.62%18.2M | -28.08%15.88M |
Income tax | 11.27%16.26M | 2.45%4.31M | -15.28%3.48M | 35.93%4.64M | 32.80%3.83M | 1.19%14.61M | 20.01%4.2M | 4.03%4.11M | 18.51%3.41M | -29.74%2.88M |
Earnings from equity interest net of tax | ||||||||||
Net income | 13.07%66.79M | 34.33%18.46M | -21.28%13.81M | 25.27%18.53M | 23.09%15.99M | -6.76%59.07M | -8.90%13.74M | 1.42%17.54M | 13.76%14.79M | -27.70%12.99M |
Net Income continuous operations | 13.07%66.79M | 34.33%18.46M | -21.28%13.81M | 25.27%18.53M | 23.09%15.99M | -6.76%59.07M | -8.90%13.74M | 1.42%17.54M | 13.76%14.79M | -27.70%12.99M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 13.07%66.79M | 34.33%18.46M | -21.28%13.81M | 25.27%18.53M | 23.09%15.99M | -6.76%59.07M | -8.90%13.74M | 1.42%17.54M | 13.76%14.79M | -27.70%12.99M |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 13.07%66.79M | 34.33%18.46M | -21.28%13.81M | 25.27%18.53M | 23.09%15.99M | -6.76%59.07M | -8.90%13.74M | 1.42%17.54M | 13.76%14.79M | -27.70%12.99M |
Basic earnings per share | 13.48%3.2 | 33.33%0.88 | -21.43%0.66 | 27.14%0.89 | 24.19%0.77 | -6.00%2.82 | -8.33%0.66 | 2.44%0.84 | 12.90%0.7 | -27.06%0.62 |
Diluted earnings per share | 13.26%3.16 | 33.85%0.87 | -21.69%0.65 | 25.71%0.88 | 24.59%0.76 | -6.06%2.79 | -8.45%0.65 | 2.47%0.83 | 14.75%0.7 | -27.38%0.61 |
Dividend per share | 4.35%0.96 | 4.35%0.24 | 4.35%0.24 | 4.35%0.24 | 4.35%0.24 | 4.55%0.92 | 4.55%0.23 | 4.55%0.23 | 4.55%0.23 | 4.55%0.23 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |